Status
Conditions
Treatments
About
The purpose of this study is to provide expanded access of givosiran to patients with Acute Hepatic Porphyria (AHP).
Full description
Choosing to participate in an expanded access program is an important personal decision. Talk with your doctor and family members or friends about deciding to join a research study. To learn more about this study, please have your doctor contact the study research staff using the Contacts provided. For general information, see the link provided in More Information.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Previously or currently participating in a givosiran clinical trial
Has any of the following laboratory parameter assessments at Screening:
On an active liver transplantation waiting list
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal